Bottom line
What is PCSRX's expense ratio?
PCSRX's expense ratio is 1.68%, or about $168 a year on every $10,000 invested. That is more expensive than 81% of commodities funds we track (median 0.9%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Jul 28, 2026
PCSRX fee table
| Net expense ratio | 1.68% |
|---|---|
| Gross expense ratio | 1.81% |
| Management fee | 0.89% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.29% |
| Acquired fund fees | 0.13% |
| Fee waiver / reimbursement | -0.13% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 28, 2026
What PCSRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCSRX | $171 | $557 | $968 | $2,116 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.68% expense ratio costs roughly $87,700 in lost growth, versus about $50,300 for the median commodities fund (0.9%).